Updated Jul 16, 2026
Verma Abhimanyu has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $65K.

Abhimanyu Verma is the Chief Technology Officer at SOPHiA GENETICS SA, a company specializing in data-driven medicine and genomic analysis. He has a background in technology and innovation within the healthcare sector.
| Role | Chief Technology Officer |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 5.3K | $5.10 | $27K |
| 2026-06-26 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 6.9K | $5.51 | $38K |
| 2026-04-08 | SOPH | SOPHiA GENETICS SA | A — Grant or award | 82.1K | $0.00 | |
| 2026-04-03 | SOPH | SOPHiA GENETICS SA | A — Grant or award | 82.1K | $0.00 |
Abhimanyu Verma is the Chief Technology Officer at SOPHiA GENETICS SA, a company specializing in data-driven medicine and genomic analysis. He has a background in technology and innovation within the healthcare sector.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($65K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Verma Abhimanyu profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.